September 11, 2017 — Veniti Inc. announced that Boston Scientific will distribute the Vici Venous Stent under a limited ...

The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) on Sept. 8 to discuss regulatory approaches for use of gadolinium-based contrast agents (GBCAs).

In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U.S. Food and Drug Administration (FDA)-cleared high sensitive Elecsys Troponin T Gen 5 blood test (Troponin T Gen 5 or TnT Gen 5) to aid in the diagnosis of heart attacks. The new nine-minute test offers faster answers clinicians can use when diagnosing heart attack.

A new National Institutes of Health-funded hypertension trial will examine the possibility of using an emergency department setting to better identify people from central cities with limited access to other venues for medical care.